Schlabe, Stefan
Boesecke, Christoph
van Bremen, Kathrin
Schwarze-Zander, Carolynne
Bischoff, Jenny
Yürüktümen, Aylin
Heine, Mario
Spengler, Ulrich
Nattermann, Jacob
Rockstroh, Jürgen K.
Wasmuth, Jan-Christian
Article History
Received: 2 February 2023
Accepted: 31 March 2023
First Online: 13 April 2023
Declarations
:
: C.B. reported Honoraria for lectures and/or consultancies from AbbVie, Gilead, Janssen, MSD, ViiV. Funding from Dt. Leberstiftung, DZIF, Hector Stiftung, NEAT ID. J.R. received honoraria for consulting or speaking at educational events. Gilead, Janssen, Merck, Theratechnologies and ViiV. K.v.B. received honoraria for educational events from Gilead and Abbvie. J.B. a stipend from the German Centre for Infection Research. S.S. received support for congress and travel expenses from Gilead, J&J, ViiV and Abbvie and a stipend from the German Centre for Infection Research not related to the topic of the manuscript. All other authors do not declare conflicts of interest.
: This single centre, retrospective study was performed according the legal and ethical requirements of the European, national and federal laws involving cohort studies in the own departments with respect to data protection and ethics. Ethical approval was waived by the local Ethics Committee of University Bonn in view of the retrospective nature of the study and all the procedures being performed were part of the routine care. No funding was granted for this study.